Recent Updates
Recently added Catalysts
BMY Neutral Sentiment

Bristol Myers Squibb to Report Results for Third Quarter 2026 on October 29, 2026

Key Takeaway: Bristol Myers Squibb has announced that it will report its financial results for the third quarter of 2026 on October 29, 2026. This announcement is part of the company's regular financial reporting schedule. Investors and analysts will be looking forward to the details of the company's performance during this period.

Market Sentiment Analysis

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+26%
120-day peak, hindsight
Typical move
1.8%
average across 15 past catalysts
Lead asset
Deucravacitinib
Phase 3 · Systemic Lupus Erythematosus

Full Press Release Details

PRINCETON, N.J.--(BUSINESS WIRE)--Bristol Myers Squibb to Report Results for Third Quarter 2026 on October 29, 2026

Frequently Asked Questions

When will Bristol Myers Squibb report Q3 2026 results?

Bristol Myers Squibb will report its Q3 2026 results on October 29, 2026.

What is the significance of the Q3 2026 report?

The Q3 2026 report will provide insights into Bristol Myers Squibb's financial performance.

Last updated: Sep 18, 2026